Jack Dempsey

Hologic (Germany) — Germany

Medicine · Health Sciences

25h-index2.9kcitations92works0.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related Molecular Pathways(18), Microtubule and mitosis dynamics(15), Advanced Breast Cancer Therapies(14), DNA Repair Mechanisms(13), Cancer, Hypoxia, and Metabolism(11)

Publications92 total

[Biological Differences between EGFR ex19del and ex21L858R-Preclinical Models Using an Engineered Pair of Isogenic NSCLC Cell Lines with CRISPR Engineering].
PubMed·2025
Altered cerebellar activation patterns in Alzheimer’s disease: An activation likelihood estimation Meta-Analysis
NeuroImage Clinical·2025· 2 citedOpen Access
Altered Cerebellar Activation Patterns in Alzheimer’s Disease and Mild Cognitive Impairment: An Activation Likelihood Estimation Meta-Analysis
2024Open Access
Re: “A Case Report of Poor Response to Selpercatinib in the Presence of a 632_633 RET Deletion” by Wijewardene et al.
Thyroid·2023· 2 citedOpen Access
Supplementary Materials and Methods from Aurora A–Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy
2023Open Access
Supplementary Materials and Methods and Supplementary Figure Legends from LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms
2023Open Access
Supplementary Table 2 from LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms
2023Open Access
Supplementary Table 3 from LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms
2023Open Access
Supplementary Table 2 from LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms
2023Open Access
Data from Aurora A–Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy
2023Open Access
Supplementary Figures from Aurora A–Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy
2023Open Access
Supplementary Table 1 from LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms
2023Open Access
Supplementary Materials and Methods from Aurora A–Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy
2023Open Access
Supplementary Table 3 from LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms
2023Open Access
Supplementary Table 4 from LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms
2023Open Access
Supplementary Table 1 from LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms
2023Open Access
Supplementary Tables from Aurora A–Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy
2023Open Access
Supplementary Table 4 from LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms
2023Open Access
Data from LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms
2023Open Access
Data from LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Richard P. Beckmann(18), Sean G. Buchanan(12), Xueqian Gong(10), Philip W. Iversen(9), Richard M. Schultz(9), Gregory P. Donoho(9), Andrew Capen(8), Yue Webster(8), Darlene Barnard(8), Mark S. Marshall(8), Harold B. Brooks(8), Robert M. Campbell(8), Charles D. Spencer(8), Scott A. Watkins(8), Farhana F. Merzoug(7), Karsten Boehnke(7), Wayne Blosser(7), David A. Barda(7), Chuan Shih(7), Bharvin K.R. Patel(7)